Editorial: Community series in recent advances in potential biomarkers for rheumatic diseases and in cell-based therapies in the management of inflammatory rheumatic diseases, volume II

• Katarzyna Bogunia-Kubik,
• Philippe Saas,
• Philippe Saas,
• Eric Toussirot

Affiliations

Katarzyna Bogunia-Kubik

Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

Philippe Saas

Institute for Advanced Biosciences, Team: Epigenetics, Immunity, Metabolism, Cell Signaling & Cancer, Inserm U 1209, CNRS UMR 5309, Université Grenoble Alpes, Grenoble, France

Philippe Saas

Etablissement Français du Sang Auvergne-Rhône-Alpes, R&D Laboratory, Grenoble, France

Eric Toussirot

Université de Franche Comté, INSERM Centre Investigation Clinique CIC-1431, CHU de Besançon, Besançon, France